Tight Budget, Turf Battles Kill One Project, Threaten Popular CGP Clinical Trials Effort
In Brief: House Subcommittee Adds 15-17% to NIH 1987 Budget; NCI to Fund Lombardi, KY Centers
DCBD Okays Concept For Molecular Probes In Colon Cancer, Two Other Organ Systems Generated Projects
HHS Proposes Six New DRGs for Leukemia, Lymphoma
14 Institutions Awarded $100 Million for AIDS Treatment Evaluation Units
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis - Vinay Prasad, oncologist and Twitter star, locked in debate over precision medicine
- GRAIL’s Megan Hall: “I think we can be confident that there is clinical benefit to implementing this technology. And I think that’s really hard to argue with.”
Mainstream epidemiologists beg to differ - One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- NCI’s Philip Castle on NHS-Galleri results: “I’m sorry that it didn’t work, but it keeps the national conversation going.”
Castle is “disappointed” by Galleri results but not discouraged by implications for MCDs
